We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $118M
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
-$34.3M
Cap. Flow
-$33.3M
Cap. Flow %
-33.2%
Top 10 Hldgs %
26.12%
Holding
294
New
64
Increased
32
Reduced
107
Closed
85

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$5.08M
2
UNH icon
UnitedHealth
UNH
+$4.05M
3
JNJ icon
Johnson & Johnson
JNJ
+$2.82M
4
NVO
Novo Nordisk
NVO
+$2.52M
5
ABBV icon
AbbVie
ABBV
+$2.39M

Top Sells

Rank Stock Value
1
RITM icon
Rithm Capital
RITM
+$4.32M
2
HRMY icon
Harmony Biosciences
HRMY
+$3.88M
3
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$3.12M
4
EFC
Ellington Financial
EFC
+$2.6M
5
MTG icon
MGIC Investment
MTG
+$2.54M

Sector Composition

Rank Sector Weight
1 Healthcare 54.58%
2 Real Estate 7.4%
3 Industrials 5.96%
4 Financials 5.87%
5 Technology 4.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVAX
226
DELISTED
Dynavax Technologies
DVAX
– –
-201,500
Closed -$2.24M
DX
227
Dynex Capital
DX
$2.99B
– –
-181,492
Closed -$2.32M
DXCM icon
228
DexCom
DXCM
$27.6B
– –
-4,171
Closed -$280K
DYN icon
229
Dyne Therapeutics
DYN
$4.04B
– –
-10,000
Closed -$359K
ECH icon
230
iShares MSCI Chile ETF
ECH
$1.01B
– –
-1,556
Closed -$42.4K
EFC
231
Ellington Financial
EFC
$1.68B
– –
-201,602
Closed -$2.6M
EIDO icon
232
iShares MSCI Indonesia ETF
EIDO
$476M
– –
-5,718
Closed -$129K
ELS icon
233
Equity Lifestyle Properties
ELS
$12.8B
– –
-20,611
Closed -$1.47M
EMBC icon
234
Embecta
EMBC
$195M
– –
-36,000
Closed -$508K
ENOV icon
235
Enovis
ENOV
$1.56B
– –
-27,500
Closed -$1.18M
EPHE icon
236
iShares MSCI Philippines ETF
EPHE
$127M
– –
-4,517
Closed -$132K
EPOL icon
237
iShares MSCI Poland ETF
EPOL
$669M
– –
-5,067
Closed -$123K
EWD icon
238
iShares MSCI Sweden ETF
EWD
$522M
– –
-2,624
Closed -$114K
EWL icon
239
iShares MSCI Switzerland ETF
EWL
$2.12B
– –
-2,094
Closed -$109K
EWN icon
240
iShares MSCI Netherlands ETF
EWN
$562M
– –
-2,179
Closed -$111K
EWQ icon
241
iShares MSCI France ETF
EWQ
$324M
– –
-2,775
Closed -$112K
EWY icon
242
iShares MSCI South Korea ETF
EWY
$21.7B
– –
-995
Closed -$63.6K
FOLD
243
DELISTED
Amicus Therapeutics
FOLD
– –
-205,000
Closed -$2.19M
LKFT
244
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
– –
-108,500
Closed -$3.12M
GPCR icon
245
Structure Therapeutics
GPCR
$3.49B
– –
-26,000
Closed -$1.14M
GSK icon
246
GSK
GSK
$103B
– –
-35,000
Closed -$1.43M
HRMY icon
247
Harmony Biosciences
HRMY
$2.04B
– –
-97,000
Closed -$3.88M
IMTX icon
248
Immatics
IMTX
$1.24B
– –
-25,000
Closed -$285K
IMVT icon
249
Immunovant
IMVT
$8.09B
– –
-35,000
Closed -$998K
INDV icon
250
Indivior Pharmaceuticals
INDV
$4.79B
– –
-242,500
Closed -$2.36M
8 9
10
11 12

Similar funds

AIS
Advocate Investing Services Woodbine, Maryland $118M AUM
IVGAI
Index Venture Growth Associates III St. Helier, Channel Islands, Jersey $118M AUM 64.91% 1-Year Est. Return
OIM
Oceanic Investment Management Douglas, Isle Of Man $118M AUM
TIP
Tandem Investment Partners Bordentown, New Jersey $118M AUM 15.76% 1-Year Est. Return
RCG
Ridge Creek Global Strongsville, Ohio $118M AUM
CWM
Capstone Wealth Management Billings, Montana $118M AUM
SPW
Stillwater Private Wealth Glen Mills, Pennsylvania $118M AUM
WLC
Walnut Level Capital Denver, Colorado $118M AUM 59.12% 1-Year Est. Return

AlphaCentric Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, AlphaCentric Advisors held 294 positions worth $100M, down 25% from $135M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

AlphaCentric Advisors withdrew a net $33.3M in Q4 2024, closing 85 positions and reducing 107 holdings. Its most notable exit was Rithm Capital, an estimated $4.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 58% a quarter earlier, followed by Real Estate and Industrials.

Against the trend, AlphaCentric Advisors opened a new position in Eli Lilly worth $4.74M.

  • AlphaCentric Advisors's largest Q4 2024 buy was Eli Lilly: 6,140 shares worth $4.74M.
  • AlphaCentric Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q4 2024, an estimated $2.03M increase.
  • AlphaCentric Advisors's biggest Q4 2024 reduction was Neurocrine Biosciences, cutting an estimated $2.33M.
  • AlphaCentric Advisors fully exited Rithm Capital in Q4 2024, selling an estimated $4.32M.
  • AlphaCentric Advisors's ten largest holdings make up 26% of its $100M portfolio in Q4 2024.
  • AlphaCentric Advisors opened 64 new positions and closed 85 in Q4 2024.
  • AlphaCentric Advisors's portfolio value fell 25% quarter-over-quarter to $100M.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.